Patents by Inventor Dirk Loeffert

Dirk Loeffert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230405057
    Abstract: The invention also relates to a microbial strain selected from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp for use as a medicament, (i) a cellular extract from a strain selected from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp for use in treating inflammatory bowel disease, (ii) the supernatant from the cell culture from a strain selected from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp for use in treating inflammatory bowel disease or, (iii) a medically active molecule or a medically active substance obtained from a strain selected from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp for use in treating inflammatory bowel disease.
    Type: Application
    Filed: October 28, 2020
    Publication date: December 21, 2023
    Inventors: Aleksander Dajkovic, Dirk Loeffert
  • Publication number: 20230340557
    Abstract: The present invention uses microfluidics droplets for studying the growth dynamics of communities of bacteria in the presence of various perturbations such as various chemicals or other microorganisms and to establish microbial assemblies model which is representative of a microbiota of interest and to examine their growth dynamics after perturbations such as with an array of chemicals or other microorganisms. In particular, the present invention refers to a method and apparatus for assessing the effect of a chemical or biological substance on the growth of microorganisms.
    Type: Application
    Filed: July 12, 2021
    Publication date: October 26, 2023
    Inventors: Aleksander Dajkovic, Guansheng Du, Dirk Loeffert
  • Publication number: 20230227920
    Abstract: In a first aspect, the present invention relates to a method of producing a library of microorganisms, the method comprising the steps of: a. providing a first fluid comprising at least one single cell, b. dispersing said first fluid comprising at least one single cell in a second fluid, thereby obtaining a plurality of single-layer microfluidic droplets, wherein at least one single- layer microfluidic droplet comprises at least one single cell, wherein the second fluid is immiscible with the first fluid, c. optionally, adding to said at least one single-layer microfluidic droplet a third fluid comprising a sensing compound, wherein the third fluid is miscible with said first fluid, and wherein the third fluid is immiscible with said second fluid, d. injecting said at least one single-layer microfluidic droplet optionally comprising the sensing compound into a fourth fluid, wherein said fourth fluid is immiscible with said second fluid, thereby obtaining at least one double-layer microfluidic droplet, e.
    Type: Application
    Filed: June 14, 2021
    Publication date: July 20, 2023
    Inventors: Guansheng Du, Laurine Thomas, Aleksander Dajkovic, Dirk Loeffert
  • Patent number: 11597963
    Abstract: The invention relates to a method for the identification of a first microorganism potentially secreting an effector compound, said first microorganism thereby having either i. an inhibitory effect on the cell division activity of a second microorganism or ii. an enhancing effect on the cell division activity of a second microorganism, the method comprising: a. providing a cell from a first microorganism which potentially produces an effector compound of interest and a cell from a second detector microorganism; b. introducing both cells into a microdroplet for incubation; c. introducing the microdroplet into a microfluidic system; d. analyzing in said microfluidic system the cell of the second microorganism for the exhibition of an enhanced growth effect or the exhibition of an inhibited growth effect stemming from said effector compound. The invention also relates to a microorganism or effector compound identified by the method according to the invention.
    Type: Grant
    Filed: November 9, 2018
    Date of Patent: March 7, 2023
    Assignee: BIOMILLENIA SAS
    Inventors: Dirk Löffert, Eric Shiue, Aleksander Dajkovic, Guansheng Du
  • Publication number: 20220409686
    Abstract: The invention relates to a pharmaceutical composition comprising (i) a live strain from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp, (ii) an attenuated strain from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp or, (iii) a medically active substance isolated from a strain from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp.
    Type: Application
    Filed: October 28, 2020
    Publication date: December 29, 2022
    Inventors: Aleksander Dajkovic, Dirk Loeffert
  • Publication number: 20220370515
    Abstract: The invention relates to a pharmaceutical composition comprising (i) a live strain from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp, (ii) an attenuated strain from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp or, (iii) a medically active substance isolated from a strain from the genus of Kazachstania spp, Acetobacter spp. and/or Stenotrophomonas spp. These may be used to treat pancreatic cancer.
    Type: Application
    Filed: October 28, 2020
    Publication date: November 24, 2022
    Inventors: Dirk Loeffert, Aleksander Dajkovic
  • Patent number: 11448645
    Abstract: Cultivation and/or test-system comprising at least two cultivation spaces combined in a microparticle, wherein the sperically shaped microparticle comprises, (i) a first cultivation space in the center core of said spherically shaped microparticle, (ii) a second cultivation space in the wall surrounding the core of said microparticle, (iii) wherein the wall surrounding the core allows for the exchange of molecules as, salts, nutrients, peptides, chemicals and other compounds in order for the cells in the first cultivation space to interact with the cells in second cultivation space and vice versa. In the test system, the cells are co-cultivated and the microparticles are then selected based on the phenotype of the cells in the first or second cultivation space.
    Type: Grant
    Filed: March 2, 2018
    Date of Patent: September 20, 2022
    Assignee: Biomillenia SAS
    Inventors: Dirk Loeffert, Aleksander Dajkovic, Thomas Duboys
  • Publication number: 20210131946
    Abstract: The invention relates to a microfluidic system in which the droplets flow through an off-chip delay line in a linear sequential order. This ensures that all the droplets are incubated for the same amount of time and under the same conditions as they flow through the delay line. The invention further relates to the use of this microfluidic system for high throughput screening methods or in vitro evolution methods.
    Type: Application
    Filed: January 18, 2018
    Publication date: May 6, 2021
    Inventors: Guansheng Du, Dirk Löffert, Eric Shiue
  • Publication number: 20200263225
    Abstract: The invention relates to a method for the identification of a first microorganism potentially secreting an effector compound, said first microorganism thereby having either i. an inhibitory effect on the cell division activity of a second microorganism or ii. an enhancing effect on the cell division activity of a second microorganism, the method comprising: a. providing a cell from a first microorganism which potentially produces an effector compound of interest and a cell from a second detector microorganism; b. introducing both cells into a microdroplet for incubation; c. introducing the microdroplet into a microfluidic system; d. analyzing in said microfluidic system the cell of the second microorganism for the exhibition of an enhanced growth effect or the exhibition of an inhibited growth effect stemming from said effector compound. The invention also relates to a microorganism or effector compound identified by the method according to the invention.
    Type: Application
    Filed: November 9, 2018
    Publication date: August 20, 2020
    Inventors: Dirk Löffert, Eric Shiue, Aleksander Dajkovic, Guansheng Du
  • Patent number: 10648031
    Abstract: The present invention is directed to novel methods and kits to be employed for preparing adapter-ligated amplicons or a sequencing library of a target DNA, respectively.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: May 12, 2020
    Assignee: QIAGEN GmbH
    Inventors: Nan Fang, Dirk Loeffert
  • Publication number: 20200003770
    Abstract: Cultivation and/or test-system comprising at least two cultivation spaces combined in a microparticle, wherein the sperically shaped microparticle comprises, (i) a first cultivation space in the center core of said spherically shaped microparticle, (ii) a second cultivation space in the wall surrounding the core of said microparticle, (iii) wherein the wall surrounding the core allows for the exchange of molecules as, salts, nutrients, peptides, chemicals and other compounds in order for the cells in the first cultivation space to interact with the cells in second cultivation space and vice versa. In the test system, the cells are co-cultivated and the microparticles are then selected based on the phenotype of the cells in the first or second cultivation space.
    Type: Application
    Filed: March 2, 2018
    Publication date: January 2, 2020
    Inventors: Dirk Loeffert, Aleksander Dajkovic, Thomas Duboys
  • Publication number: 20190382711
    Abstract: In a first aspect, the present invention relates to a method for detecting and/or selecting a microorganism with a desired trait comprising the steps of (a) providing a composition comprising two or more microorganisms, (b) subjecting said two or more microorganisms to one of the following reactions leading to a change in the genetic composition in at least one microorganism, (i) natural transformation, (ii) transduction by phage, (iii) conjugation; (c) encapsulating each microorganism in a single microfluidic droplet together with an indicator molecule capable of detecting the presence of the desired trait, (d) incubating the encapsulated microorganism together with the indicator molecule under conditions that allow the detection of the desired trait, (e) sorting said droplets in a microfluidic system into at least (i) one group where the desired trait is not detectable and (ii) one group where the desired trait is detectable if present.
    Type: Application
    Filed: January 26, 2018
    Publication date: December 19, 2019
    Inventors: Aleksander Dajkovic, Dirk Löffert
  • Publication number: 20190316165
    Abstract: A method for the analysis of microorganisms, which produce a compound, the method comprising: a. providing a microorganism which produces a compound of interest and a detector microorganism which comprises a reporter gene or reporter gene operon, wherein the microorganism producing said compound of interest and the detector microorganism are combined into single droplets, wherein each droplet comprises at least one cell of each strain; b. subjecting the droplets to a microfluidic system; c. analyzing the droplets for the activation of the reporter gene of the detector strain; d. sorting and collecting the droplets comprising the detector microorganism with expressed reporter gene.
    Type: Application
    Filed: November 9, 2017
    Publication date: October 17, 2019
    Inventors: Dirk Loeffert, Eric Shiue, Guansheng Du
  • Publication number: 20190194718
    Abstract: The present invention is directed to novel methods, kits and uses to be employed for the generation of tagged DNA fragments of a target DNA and nucleic acid molecules associated therewith
    Type: Application
    Filed: December 11, 2014
    Publication date: June 27, 2019
    Inventors: Ioanna Andreou, Nan Fang, Dirk Loeffert, Annika Piotrowski
  • Patent number: 10323273
    Abstract: The present invention relates to methods and uses where a combination of (i) an enzyme exhibiting 5??3? exonuclease activity and specifically degrading 5?-phosphorylated strands of double-stranded nucleic acids is used, and (ii) one or more primer pair(s), each primer being 5? phosphorylated, in a method comprising at least a first and a second amplification reaction of a first and a second template, respectively, for preventing contamination of the second amplification reaction with amplification products of the first amplification reaction, as well as novel methods and kits using the combination. Also, the present invention relates to kits comprising the enzyme and either 5?-phosphorylated primers or a polynucleotide kinase.
    Type: Grant
    Filed: May 28, 2015
    Date of Patent: June 18, 2019
    Assignee: Qiagen GmbH
    Inventors: Nan Fang, Dirk Loeffert, Christine Runde
  • Patent number: 10087482
    Abstract: The present invention relates to a reaction mixture for the amplification of nucleic acids, the non-methylated cytosine bases of which have been converted to uracil bases by means of a bisulfition reaction. The invention also discloses methods for amplifying bisulfited nucleic acid and for determining the nucleic acid methylation state, and also kits based on the reaction mixture according to the invention.
    Type: Grant
    Filed: February 6, 2009
    Date of Patent: October 2, 2018
    Assignee: QIAGEN GMBH
    Inventors: Christian Korfhage, Dirk Loeffert, Ralf Peist, Nicolas Rudinger
  • Publication number: 20180057876
    Abstract: The present invention is directed to novel methods and kits to be employed for preparing adapter-ligated amplicons or a sequencing library of a target DNA, respectively.
    Type: Application
    Filed: November 9, 2017
    Publication date: March 1, 2018
    Inventors: Nan Fang, Dirk Loeffert
  • Publication number: 20170283869
    Abstract: The present invention is directed to novel methods and kits to be employed for preparing adapter-ligated amplicons or a sequencing library of a target DNA, respectively.
    Type: Application
    Filed: August 21, 2015
    Publication date: October 5, 2017
    Inventors: Nan Fang, Dirk Loeffert
  • Patent number: 9683255
    Abstract: The present invention concerns a method for activating a nucleic acid for a polymerase reaction with the steps: (a) Heating a nucleic acid to a temperature of 55° C. to 80° C., (b) cooling the nucleic acid to a temperature at which a polymerase shows no substantial decrease in activity, and (c) starting the polymerase reaction by the addition of a heat-labile polymerase to the nucleic acid.
    Type: Grant
    Filed: September 11, 2006
    Date of Patent: June 20, 2017
    Assignee: QIAGEN GMBH
    Inventors: Christian Korfhage, Dirk Löffert
  • Patent number: 9611506
    Abstract: This invention relates to a process for synthesis of a cDNA in a sample, in an enzymatic reaction, whereby the process comprises the steps: simultaneous preparation of a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, a buffer, at least one ribonucleotide, at least one deoxyribonucleotide, an anchor oligonucleotide; addition of a sample that comprises a ribonucleic acid; and incubation of the agents of the previous steps in one or more temperature steps, which are selected such that the first enzyme and the second enzyme show activity. The invention further relates to a reaction mixture that comprises a first enzyme with polyadenylation activity, a second enzyme with reverse transcriptase activity, optionally a buffer, optionally at least one ribonucleotide, optionally at least one deoxyribonucleotide, and optionally an anchor oligonucleotide. Moreover, the invention relates to a kit that comprises a corresponding reaction mixture.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: April 4, 2017
    Assignee: QIAGEN, GMBH
    Inventors: Holger Engel, Subrahmanyam Yerramilli, Martin Kreutz, Dirk Loeffert, Christian Korfhage